Hester Biosciences Ltd.
| BSE: 524669 | Sector: Health care |
| NSE: HESTERBIO | ISIN Code: INE782E01017 |
| BSE 00:00 | 23 Jul | 2411.55 |
-13.75 (-0.57%) |
OPEN
2415.00 |
HIGH
2433.10 |
LOW
2394.05 |
| NSE 00:00 | 23 Jul | 2411.70 |
-9.10 (-0.38%) |
OPEN
2450.00 |
HIGH
2450.00 |
LOW
2394.05 |
| OPEN | 2415.00 |
| PREVIOUS CLOSE | 2425.30 |
| VOLUME | 689 |
| 52-Week high | 3180.00 |
| 52-Week low | 1246.00 |
| P/E | 47.05 |
| Mkt Cap.(Rs cr) | 2,052 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Hester Biosciences Ltd. (HESTERBIO) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 694.00 | 6.80 | 0.99 | 3211.14 |
| Cipla | 948.00 | -1.60 | -0.17 | 2318.17 |
| Dr Reddy's Labs | 5422.90 | 40.05 | 0.74 | 2186.40 |
| Aurobindo Pharma | 963.70 | -8.20 | -0.84 | 1872.74 |
| Alkem Lab | 3393.50 | 20.50 | 0.61 | 1685.08 |
| Cadila Health. | 615.05 | -5.65 | -0.91 | 1476.20 |
| Divi's Lab. | 4823.95 | -19.30 | -0.40 | 1372.71 |
| Glenmark Pharma. | 649.85 | -22.10 | -3.29 | 1354.55 |
| Lupin | 1181.35 | 1.40 | 0.12 | 1258.62 |
| Alembic Pharma | 946.65 | 2.25 | 0.24 | 1175.39 |
| Torrent Pharma. | 3043.85 | 31.55 | 1.05 | 1137.85 |
| Laurus Labs | 647.55 | -6.45 | -0.99 | 956.11 |
| Gland Pharma | 4016.25 | -127.35 | -3.07 | 772.86 |
| Abbott India | 17809.30 | 297.10 | 1.70 | 690.69 |
| Ajanta Pharma | 2167.00 | 54.20 | 2.57 | 675.64 |
| Ipca Labs. | 2202.45 | 25.10 | 1.15 | 652.46 |
| Wockhardt | 547.85 | -2.00 | -0.36 | 593.29 |
| Granules India | 379.50 | -4.25 | -1.11 | 552.78 |
| Pfizer | 5626.45 | 16.00 | 0.29 | 509.13 |
| Sanofi India | 7991.40 | -14.25 | -0.18 | 477.60 |
Quick Links for Hester Biosciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
